Canaccord analyst Richard Close lowered the firm’s price target on DocGo to $5 from $9 and keeps a Buy rating on the shares. The firm said the company provided some transparency on the core business expectations for 2024 and 2025, and the contribution from migrant-related revenue in the current year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCGO:
- DocGo price target lowered to $6.50 from $8 at Stifel
- DocGo price target lowered to $9 from $10 at Canaccord
- DocGo signs extension, starts transition of asylum seeker contract with NYC HPD
- DocGo contract transition could remove overhang, says Canaccord
- DocGo’s Subsidiary Renews NYC Asylum Seeker Support Contract
